Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
TRG Latin America Acquisitions Corp. Announces Closing of Partial Exercise of IPO Over-Allotment Option
-
BiomX Inc. Received NYSE American Notification Letter Regarding Stockholders' Equity Deficiency
-
Churchill Announces TSXV Approval of Golden Baie Option Agreement
-
Forte Minerals Provides Updates on Alto Ruri and Pucarini Projects, Peru
-
Arverne Group: ORANE Issuance Plan of a Minimum Amount of €33 Million, Intended to Be Primarily Subscribed by Bpifrance, Together With Longstanding Investors Eiffel Essentiel, ADEME Investissement
-
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Operational Highlights
-
Virtus Total Return Fund Inc. Discloses Sources of Distribution – Section 19(a) Notice
-
CBL Properties Closes $176 Million Non-Recourse Financing
-
Tidal Wave Auto Spa Steps Up to the Plate for Year Three with the Atlanta Braves
-
Radiance Technologies Promotes Space Group Vice President Paul Lithgow to Chief Growth Officer
-
HAFNIA LIMITED: Cancellation of Treasury Shares
-
Catherine Hershey Schools for Early Learning Hosts Fourth Annual Early Childhood Education Leaders Summit in Hershey
-
Forian Inc. Announces Fourth Quarter and Full Year 2025 Financial Results
-
Auddia Announces Reverse Stock Split
-
AT&T Declares Dividends on Common and Preferred Shares
-
Six Nuveen Closed-End Funds Announce Availability of 19(a) Notices
-
Core & Main Announces Changes to Board of Directors and Executive Chair
-
Verde Clean Fuels, Inc. Reports Q4 and FY 2025 Results
-
Virtus Artificial Intelligence & Technology Opportunities Fund Discloses Sources of Distribution – Section 19(a) Notice
-
indie Announces New Employee Inducement Grants
-
Crescent Biopharma Announces Grants of Inducement Awards
-
Aqua Metals to Announce Fourth Quarter and Full-Year 2025 Financial Results and Host Investor Conference Call on March 31, 2026
-
Lifeloc Reports 2025 Full Year Results
-
Intensity Therapeutics Reports 2025 Year End Financial Results and Highlights, and Provides Corporate Update
-
iAnthus Reports Fiscal Fourth Quarter and Full Year 2025 Financial Results
-
Virtus Diversified Income & Convertible Fund Discloses Sources of Distribution – Section 19(a) Notice
-
Significant Selection of Ancient Art & Jewellery Is For Offer At Apollo Art Auctions
-
ALLIANCEBERNSTEIN NATIONAL MUNICIPAL INCOME FUND, INC. REPORTS FIRST QUARTER EARNINGS
-
KBRA Releases Research – Private Credit: Deep Dive on AI and Software
-
Cody Burgat Emphasizes Risk Management as a Primary Principle for Modern Traders
-
Cody Burgat Explains Why Artificial Intelligence Does Not Really Eliminate Risk in Trading
-
Cue Biopharma Announces CEO Transition
-
FiEE, Inc. to Invest Approximately $3.0 Million to Build AI Music Ecosystem
-
NorthStrive Biosciences Signs Licensing Agreement Amendment with MOA Life Plus [KOSDAQ: 142760] for Dual Myostatin Assets Targeting Muscle Preservation in Combination with GLP-1 Treatments
-
SPAR Group, Inc. Announces Timing of Fiscal 2025 Fourth Quarter and Full Year Results Conference Call
-
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Entera Bio Announces Full Year 2025 Financial Results and Provides Business Updates
-
Fastenal Company Announces Conference Call to Review 2026 First Quarter Earnings
-
Protium Clean Energy Corp. Closes Oversubscribed Private Placement Offering
-
Presurance Holdings Reports 2025 Fourth Quarter Financial Results
-
Innoviz Announces Receipt of Nasdaq Non-Compliance Letter
-
Immersion Corporation Receives Nasdaq Staff Additional Delinquency Notice
-
Early Warning News Release of X Machina Capital Strategies (XMC)
-
J.P. Morgan to Transfer 14 ETFs From Current Exchanges
-
Dawson Geophysical to Issue Fourth Quarter and Year End 2025 Results and Hold Investor Conference Call
-
Health In Tech Announces Closing of $7.0 Million Private Placement
-
Quanterix Corporation Announces Date of 2026 Annual Meeting
-
NYMOX Provides Recent Updates
-
Angelalign Technology (6699.HK) Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth
-
Transform 2026 Concludes with 4,000+ Leaders Defining the Human + AI Equation

